Date Filed | Type | Description |
05/26/2023 |
4
| Tiller Jane (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.
Txns:
| Granted 12,500 options to buy
@ $7.06, valued at
$88.3k
|
|
05/26/2023 |
4
| SEKHRI PAUL J (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.
Txns:
| Granted 12,500 options to buy
@ $7.06, valued at
$88.3k
|
|
05/26/2023 |
4
| SCHNEIDER PHILLIP M (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.
Txns:
| Granted 12,500 options to buy
@ $7.06, valued at
$88.3k
|
|
05/26/2023 |
4
| Lynch Casey (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.
Txns:
| Granted 12,500 options to buy
@ $7.06, valued at
$88.3k
|
|
05/26/2023 |
4
| Le Goff Corinne (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.
Txns:
| Granted 12,500 options to buy
@ $7.06, valued at
$88.3k
|
|
05/26/2023 |
4
| Aurentz Vincent (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.
Txns:
| Granted 12,500 options to buy
@ $7.06, valued at
$88.3k
|
|
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/31/2022 |
4
| Tiller Jane (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.
Txns:
| Granted 12,367 options to buy
@ $4.4, valued at
$54.4k
|
|
05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/31/2022 |
4
| Le Goff Corinne (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.
Txns:
| Granted 12,367 options to buy
@ $4.4, valued at
$54.4k
|
|
05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/21/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/11/2022 |
4
| Perera Philip (CMO) has filed a Form 4 on Longboard Pharmaceuticals, Inc.
Txns:
| Granted 95,000 options to buy
@ $4.2, valued at
$399k
|
|
11/17/2021 |
4
| Tiller Jane (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.
Txns:
| Granted 12,367 options to buy
@ $6.21, valued at
$76.8k
Granted 5,152 options to buy
@ $6.21, valued at
$32k
|
|
11/17/2021 |
3
| Tiller Jane (Director) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/11/2021 |
4
| Le Goff Corinne (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.
Txns:
| Granted 12,367 options to buy
@ $16, valued at
$197.9k
Granted 13,397 options to buy
@ $16, valued at
$214.4k
|
|
03/11/2021 |
4
| Lynch Casey (Director) has filed a Form 4 on Longboard Pharmaceuticals, Inc.
Txns:
| Granted 12,367 options to buy
@ $16, valued at
$197.9k
Granted 14,428 options to buy
@ $16, valued at
$230.8k
|
|
03/11/2021 |
3
| ARENA PHARMACEUTICALS INC (10% Owner) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| Le Goff Corinne (Director) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| Lynch Casey (Director) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| SEKHRI PAUL J (Director) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| SCHNEIDER PHILLIP M (Director) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| Aurentz Vincent (Director) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| Roberts Brandi (CFO) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |
03/11/2021 |
3
| Perera Philip (Chief Medical Officer) has filed a Form 3 on Longboard Pharmaceuticals, Inc. |